GenBioPro Suit Against FDA May Preserve Generic Mifepristone Approval

Generic Sales To Be Banned On 21 April Without Supreme Court Intervention

 
• By Chloe Kent
  
Woman with abortion pill
Mifepristone has faced ongoing legal challenges since the abolition of Roe v. Wade • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin